Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NoAb BioDiscoveries is a contract research organization (CRO) that provides specialized preclinical research services to the pharmaceutical and biotechnology industries. The company focuses on ADME (Absorption, Distribution, Metabolism, and Excretion), pharmacokinetics (PK), and bioanalytical services to support drug discovery and development. Their offerings include in vitro assays, in vivo animal studies, and metabolite identification for both small molecules and biologics. By providing high-quality data and expert analysis, NoAb BioDiscoveries helps clients optimize lead candidates and prepare for regulatory submissions. The firm is headquartered in Ontario, Canada, and serves a global client base. Their expertise is particularly noted in the area of mass spectrometry-based bioanalysis and metabolic profiling.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NoAb BioDiscoveries.